Business Unit Lead Lung; m​/w​/d

At Johnson & Johnson,we believe health is everything. Our strength in healthcare innovation empowers us to build aworld where complex diseases are prevented, treated, and cured,where treatments are smarter and less invasive, and solutions are personal.

Through our expertise in Innovative Medicine and Med Tech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.

Learn more at .

As guided by Our Credo, Johnson & Johnson is responsible to our employees who work with us throughout the world. We provide an inclusive work environment where each person is considered as an individual. At Johnson & Johnson, we respect the diversity and dignity of our employees and recognize their merit.

Job Function:

Job Sub Function:

Job Category:

All Job Posting Locations:

Job Description:

Internal Job Posting: 20.05.2026 – 03.06.2026

For our Commercial Oncology Team based in Neuss we are currently searching for a

Business Unit Lead Lung (m/w/d)

The Business Unit Lead (BUL) Lung is accountable for accelerating growth and maximizing the full potential of the Lung oncology portfolio in Germany, Rybrevant and Lazcluze in a highly competitive NSCLC environment.

This role is responsible for delivering short- and long-term performance, driving launch excellence, rapid market adoption, and competitive out performance, while ensuring strong cross-functional orchestration, patient-centric impact, and the effective use of digital innovation and artificial intelligence to enhance decision-making and execution.

Your

Key Responsibilities:

1. Growth Acceleration & Business Performance

• Deliver Net Sales vs. target and outperform Market Share in NSCLC segments for Rybrevant and Lazcluze

• Own full P&L accountability, including:

  • Maintaining forecast accuracy (±X%)

  • Optimizing ROI on key investments

  • Driving effective resource prioritization

• Establish and rigorously track growth drivers:

  • Increase patient identification and treatment initiation rates

  • Improve eligible patient capture across the treatment pathway (%)

• Continuously identify and unlock growth opportunities across the treatment pathway

2. Launch Excellence & Competitive Execution

• Lead best-in-class execution of launches and indication expansions, delivering time-to-peak sales aligned with plan

• Translate clinical differentiation into measurable adoption:

  • Increase% of target HCPs actively prescribing

• Ensure rapid and broad access:

  • Accelerate time-to-reimbursement and access milestones

  • Improve access success rate (payer/hospital level)

• Remove barriers to uptake with direct impact on:

  • Prescription volume growth

  • Competitor share evolution

3. Strategic Leadership

• Define and implement a clear, growth-driven Lung strategy aligned with brand, OpCo, and EMEA TA priorities

• Drive sharp prioritization toward initiatives with highest impact and ROI

• Ensure disciplined execution:

  • Deliver% of strategic initiatives on time

  • Track ROI and impact of key initiatives

• Translate strategy into execution-ready plans with clear milestones and measurable outcomes

4. Cross-Functional Orchestration and Stakeholder Engagement

• Lead the BU through solid-line (Marketing, Sales) and dotted-line leadership (Medical, MSLs, HEMAR, Business Excellence)

• Ensure seamless collaboration to deliver integrated execution through:

  • Cross-functional plan delivery rate (%)

• Drive a unified customer engagement model:

  • Improve reach & frequency in priority customer segments

• Strengthen stakeholder relationships to drive treatment adoption and prescribing behavior

• Ensure consistent customer-centric approach and value delivery

5. Insights, Analytics & Adaptation

• Monitor market dynamics, competitor moves, and clinical developments in real time

• Implement performance dashboards tracking key commercial KPIs

• Translate insights into rapid decision-making:

  • Reduce decision-to-implementation cycle time

• Embed a data-driven culture:

  • Increase data utilization in key decisions (%)

  • Ensure frequent strategy adjustments based on insights

6. Leadership, Culture & Talent

• Build and lead a high-performing, agile team focused on growth delivery

• Drive talent development and strengthen leadership pipeline:

  • Ensure succession coverage for critical roles

• Foster a high-performance culture:

  • Maintain strong retention rate (especially top talent)

  • Increase high performer ratio

• Role model J&J Credo and patient-centric mindset:

  • Drive employee engagement and leadership feedback scores

Required Qualifications & Capabilities:

• Strong leadership experience in oncology, ideally lung cancer or launch environments

• Proven track record in driving growth in competitive markets

• Experience managing complex, cross-functional teams and matrix organizations

• Deep understanding of oncology ecosystems (clinical, access, stakeholder landscape)

• Strong strategic thinking combined with hands-on execution focus

• Excellent stakeholder management and influencing…